cerebral amyloidoma
Recently Published Documents


TOTAL DOCUMENTS

19
(FIVE YEARS 1)

H-INDEX

5
(FIVE YEARS 0)

2021 ◽  
Vol 8 (1) ◽  
pp. 781-786
Author(s):  
Haruki YAMASHITA ◽  
Motoaki FUJIMOTO ◽  
Ryuta YOKOGAWA ◽  
Tomoaki TAGUCHI ◽  
Jiro OHARA ◽  
...  

2020 ◽  
Vol 45 (10) ◽  
pp. 838-839
Author(s):  
Frederik Soffers ◽  
Sarah Ceyssens ◽  
Wendi Buffet ◽  
Didier de Surgeloose ◽  
Roeland Crols
Keyword(s):  

2020 ◽  
Vol 45 (4) ◽  
pp. e206-e207 ◽  
Author(s):  
Laura Rozenblum ◽  
Marc Bertaux ◽  
Franck Bielle ◽  
Morgan Ollivier ◽  
Sylvain Choquet ◽  
...  

Cureus ◽  
2020 ◽  
Author(s):  
Ashima Kapoor ◽  
Anusha Manje Gowda ◽  
Supreet Kaur ◽  
Elias Estifan ◽  
Michael Maroules

2019 ◽  
Vol 46 (5) ◽  
pp. 336-339
Author(s):  
Alireza Radmanesh ◽  
Matthew D. Wood ◽  
Andrew W. Bollen

2019 ◽  
Vol 125 ◽  
pp. 449-450
Author(s):  
Anna Maheux ◽  
Julien Savatovsky ◽  
Augstin Lecler
Keyword(s):  

2018 ◽  
Vol 2018 ◽  
pp. 1-6
Author(s):  
Geetha Jagannathan ◽  
Guldeep Uppal ◽  
Kevin Judy ◽  
Mark T. Curtis

Cerebral amyloidomas are rare cerebral mass lesions often associated with significant morbidity. Cerebral amyloid accumulation can be the result of a number of disease states and it is crucial for proper patient care to identify the pathogenic process leading to amyloidoma formation. Low grade clonal B-cell processes are one cause of cerebral amyloidomas. We report a case of an 87-year-old woman who presented with a lymphoplasmacytic lymphoma associated cerebral amyloidoma complicated by cerebral hemorrhage, discuss the proper workup of this disease entity, and present a review of the literature on this topic.


2017 ◽  
Vol 28 (2) ◽  
pp. 234-239 ◽  
Author(s):  
Katharina Heß ◽  
Jan Purrucker ◽  
Ute Hegenbart ◽  
Benjamin Brokinkel ◽  
Rouven Berndt ◽  
...  

2016 ◽  
Author(s):  
Maxime St-Amant ◽  
Frank Gaillard
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document